3Mario Venditti, Marco Falcone, Alessandra Micozzi, et al. Staphylococcus aureus bacteremia in patients with hematologic malignancies a retrospective case coutrol study[ J ]. Journal of Hematology, 2003,88 (08) :923 － 930.
4Garner JS, Jarvis WR, Err, off TG, et al. CDC definitions for nosocomial infections[ J ]. Am J Infect Control, 1988,16:128 － 140.
5Gianluigi Ferretti, Mario Mandala, Serena Di Cosimo, et al. Catheter -related bloodstream infections, part I: pathogenesis, diagnosis, and management[ J ]. Cancer Control,2002,9(6) :513 － 523.
6Costa S, Barone A, Van der Heijden I, et al. Study of possible sources of bloodstream infection due to coagulase negative staphylococcus in cancerpatients[ M ].103rd ASM General Meeting, 2003. Washington DC.
7Silvia F Costa, Marise H Miceli, Elias J Anaissie. Mucosa or skin as source of coagulase- negative staphylococcal bacteremia [ J ]? THE LANCET Infection Diseases,2004,4:278 － 286.
9Gianluigi Ferretti, Mario Mandala, S, erena Di Cosimo, et al. Catheter - related bloodstream infections, part Ⅱ: specific pathogens and prevention [ J ]. Cancer Control, 2003,10( 1 ) :79 － 91.
10Wang- Huei S, Wen - Je K, Jann - Tay W, et al. Evaluation of antiseptic - impregated central venous catheters for prevention of catheter - related infection in intensive care unit patients [ J ] . Diagn Microbiol Infect Dis,2000,38:1 － 5,.
二级参考文献19
1Barbara S R, Gail L W, Richard B T, et al. Specimen processing [A]. Murray P R, Baron E J, Praller M A, et al. Manual of Clinical Microbiology [M]. 7th edition,Washington, D. C: ASM Press, 1999: 65
2National Committee for Clinical Laboratory Standards,2002. Performance standards for antimicrobial susceptibility testing. Approved Standard [S]. 12th edition. M100-S12. NCCLS, Wayne, pa Ps0-58966-70
3CDSC. Staphylococcus aureus bacteraemia: England and Wales, January to December 2000 [J]. Commun Dis Rep CDR Weekly, 2000,10:143
4Kloos W E, Bannerman T L. Staphylococcus and Micrococcus [A]. Murray P R, Baron E J, Pfaller M A, et al.Manual of clinical microbiology [M]. 7th edition. Washington, DC: ASM Press, 1999: 264
5Santos Sanches I, Mato R, de Lencastre H, et al. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and
6CDSC. Acinetobacter spp and Enterococcus spp bacteraemia, England and Wales: 1999 and 2000. Common Dis Rep CDR Wkly[serial online]2001[cited 18 july 2002];11(24): bacteraemia. Available at＜http://www. phls.org. uk/publications/cdr/archive/bacteraemiaarch
7Richet H M, Benbachir M, Brown D E, et al. Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus?[J]. Infect Control Hosp Epidemiol, 2003,24(5):334
8Wenzel RP. Prevention and control of nosocomial infections. 3rd ed.Baltimore Williams & Wilkins , 1997. 711-770.
9Diamantis I,Bassetti S,Erb P,et al.High prevalence and coinfection rate of hepatitis G and C infection in intravenous drug addicts[].Journal of Hepatology.1997
10Fowler-VG JR,Li J,Corey-GR,et al.Role of echocardiography in evaluation of patients with staphylococcus aureus bacteremia: experience in 103 patients[].Journal of the American College of Cardiology.1997
